id	sid	eid	entity	type
bptjm-41	1	1	berkeley pharma tech journal	ORG
bptjm-41	2	1	march 10	DATE
bptjm-41	2	2	2023	CARDINAL
bptjm-41	2	3	april 6	DATE
bptjm-41	2	4	2023	CARDINAL
bptjm-41	2	5	june 30	DATE
bptjm-41	2	6	2023	CARDINAL
bptjm-41	2	7	4.0	CARDINAL
bptjm-41	4	1	two	CARDINAL
bptjm-41	4	2	~10%	PERCENT
bptjm-41	6	1	hydroxychloroquine	PERSON
bptjm-41	8	1	james w. larrick	PERSON
bptjm-41	8	2	m.d. ph.d	PERSON
bptjm-41	8	3	w. larrick	PERSON
bptjm-41	8	4	1.1 autophagy autophagy	DATE
bptjm-41	8	5	christian de duve	ORG
bptjm-41	8	6	1974	DATE
bptjm-41	13	1	2013	DATE
bptjm-41	14	1	1.2	CARDINAL
bptjm-41	14	2	south america	LOC
bptjm-41	15	1	europe	LOC
bptjm-41	16	1	1820	DATE
bptjm-41	17	1	bayer	ORG
bptjm-41	18	1	3-methyl-chloroquine	QUANTITY
bptjm-41	18	2	germans	NORP
bptjm-41	18	3	world war ii	EVENT
bptjm-41	19	1	americans	NORP
bptjm-41	19	2	north africa	GPE
bptjm-41	19	3	the united states	GPE
bptjm-41	19	4	1947	DATE
bptjm-41	20	1	1	CARDINAL
bptjm-41	20	2	2	CARDINAL
bptjm-41	22	1	3	CARDINAL
bptjm-41	22	2	4	DATE
bptjm-41	22	3	5	CARDINAL
bptjm-41	23	1	berkeley pharma tech journal	ORG
bptjm-41	23	2	2	CARDINAL
bptjm-41	25	1	li et al.	PERSON
bptjm-41	25	2	6	CARDINAL
bptjm-41	26	1	covid-19	PRODUCT
bptjm-41	27	1	2020 7	DATE
bptjm-41	28	1	british	NORP
bptjm-41	28	2	covid-19	GPE
bptjm-41	29	1	ace2	ORG
bptjm-41	29	2	8	CARDINAL
bptjm-41	29	3	9	DATE
bptjm-41	30	1	10	CARDINAL
bptjm-41	31	1	11	CARDINAL
bptjm-41	31	2	12	CARDINAL
bptjm-41	32	1	13	CARDINAL
bptjm-41	32	2	t 14, 15	DATE
bptjm-41	33	1	16	CARDINAL
bptjm-41	34	1	li et al	PERSON
bptjm-41	34	2	24-month-old	DATE
bptjm-41	34	3	sprague	GPE
bptjm-41	34	4	dawley male rats	ORG
bptjm-41	34	5	0.1 mg/kg	QUANTITY
bptjm-41	34	6	weekly	DATE
bptjm-41	34	7	5 months 6	DATE
bptjm-41	35	1	13	CARDINAL
bptjm-41	35	2	6%	PERCENT
bptjm-41	35	3	13%	PERCENT
bptjm-41	35	4	0.02	CARDINAL
bptjm-41	35	5	6	CARDINAL
bptjm-41	36	1	li et al.	PERSON
bptjm-41	36	2	doeppner et al	PERSON
bptjm-41	37	1	2022	CARDINAL
bptjm-41	37	2	17	CARDINAL
bptjm-41	38	1	18	CARDINAL
bptjm-41	38	2	19	CARDINAL
bptjm-41	38	3	20	CARDINAL
bptjm-41	40	1	50 mg/kg	QUANTITY
bptjm-41	40	2	berkeley pharma tech journal	ORG
bptjm-41	40	3	3	CARDINAL
bptjm-41	40	4	28	CARDINAL
bptjm-41	40	5	age 500 days	DATE
bptjm-41	40	6	11.4%	PERCENT
bptjm-41	40	7	786 days	DATE
bptjm-41	40	8	28	CARDINAL
bptjm-41	40	9	689 days	DATE
bptjm-41	40	10	0.0002	CARDINAL
bptjm-41	41	1	11.4%	PERCENT
bptjm-41	42	1	two	CARDINAL
bptjm-41	44	1	age 500 days	DATE
bptjm-41	45	1	the next 100 days	DATE
bptjm-41	45	2	45	CARDINAL
bptjm-41	45	3	gm	ORG
bptjm-41	46	1	almost 800 days	DATE
bptjm-41	47	1	0.002	CARDINAL
bptjm-41	48	1	60 mg/kg	QUANTITY
bptjm-41	48	2	21	CARDINAL
bptjm-41	50	1	22	DATE
bptjm-41	51	1	lc3-ii	PERSON
bptjm-41	52	1	doeppner et al	PERSON
bptjm-41	52	2	lc3b-ii	ORG
bptjm-41	52	3	17	CARDINAL
bptjm-41	53	1	3	CARDINAL
bptjm-41	53	2	igf-1	ORG
bptjm-41	53	3	irs	ORG
bptjm-41	53	4	23	CARDINAL
bptjm-41	53	5	24	DATE
bptjm-41	55	1	berkeley pharma tech journal	ORG
bptjm-41	55	2	4 igfbp3	TIME
bptjm-41	55	3	igf-1	ORG
bptjm-41	56	1	25	CARDINAL
bptjm-41	57	1	igfb3	ORG
bptjm-41	58	1	igfb3	ORG
bptjm-41	58	2	26	CARDINAL
bptjm-41	58	3	27	DATE
bptjm-41	58	4	28	DATE
bptjm-41	59	1	li et al.	PERSON
bptjm-41	59	2	0.1 mg/kg	QUANTITY
bptjm-41	59	3	late middle age 6	DATE
bptjm-41	60	1	29	CARDINAL
bptjm-41	61	1	qian et al	PERSON
bptjm-41	61	2	30	CARDINAL
bptjm-41	62	1	2	CARDINAL
bptjm-41	62	2	31	DATE
bptjm-41	62	3	32	DATE
bptjm-41	62	4	33	DATE
bptjm-41	63	1	li et al	PERSON
bptjm-41	64	1	40%	PERCENT
bptjm-41	64	2	30%	PERCENT
bptjm-41	64	3	20%	PERCENT
bptjm-41	66	1	caps2	PERSON
bptjm-41	66	2	myh7	PERSON
bptjm-41	67	1	6	CARDINAL
bptjm-41	69	1	34	CARDINAL
bptjm-41	70	1	berkeley pharma tech journal	ORG
bptjm-41	70	2	5	CARDINAL
bptjm-41	70	3	the past 20 years	DATE
bptjm-41	70	4	ed non-autophagy	PERSON
bptjm-41	71	1	35	CARDINAL
bptjm-41	71	2	31	CARDINAL
bptjm-41	71	3	36	CARDINAL
bptjm-41	71	4	37	CARDINAL
bptjm-41	71	5	30	CARDINAL
bptjm-41	71	6	33	DATE
bptjm-41	74	1	li et al	PERSON
bptjm-41	74	2	6	CARDINAL
bptjm-41	76	1	38	CARDINAL
bptjm-41	77	1	li et al	PERSON
bptjm-41	77	2	doeppner et al	PERSON
bptjm-41	78	1	october 8–13, 2013	DATE
bptjm-41	78	2	italy 39	GPE
bptjm-41	84	1	40	CARDINAL
bptjm-41	84	2	38	CARDINAL
bptjm-41	85	1	south america	LOC
bptjm-41	86	1	berkeley pharma tech journal	ORG
bptjm-41	86	2	6	CARDINAL
bptjm-41	86	3	1	CARDINAL
bptjm-41	89	1	2018;38(8):653-671	CARDINAL
bptjm-41	90	1	2	CARDINAL
bptjm-41	91	1	rasmussen c	PERSON
bptjm-41	91	2	alonso p	ORG
bptjm-41	93	1	2021;20(3):353	CARDINAL
bptjm-41	94	1	3	CARDINAL
bptjm-41	94	2	chou ac	PERSON
bptjm-41	94	3	fitch	PERSON
bptjm-41	96	1	1992;51(26):2073-2078	CARDINAL
bptjm-41	97	1	slater af	PERSON
bptjm-41	97	2	cerami a. inhibition	PERSON
bptjm-41	100	1	5	CARDINAL
bptjm-41	101	1	coronado lm	PERSON
bptjm-41	101	2	spadafora c. malarial	PERSON
bptjm-41	103	1	2014;1840(6):2032-2041	CARDINAL
bptjm-41	104	1	doi:10.1016/j.bbagen.2014.02.009	ORG
bptjm-41	104	2	6	CARDINAL
bptjm-41	105	1	li w	PERSON
bptjm-41	105	2	cai y	PERSON
bptjm-41	107	1	2022;13(6):454	CARDINAL
bptjm-41	108	1	lisanti mp	PERSON
bptjm-41	109	1	covid-19	PERSON
bptjm-41	111	1	2020;12(8):6511-6517	DATE
bptjm-41	112	1	doi:10.18632/aging.103001	ORG
bptjm-41	112	2	8	CARDINAL
bptjm-41	113	1	kim km	PERSON
bptjm-41	113	2	noh jh	PERSON
bptjm-41	113	3	identi	PERSON
bptjm-41	113	4	dpp4	PERSON
bptjm-41	115	1	2017;31(15):1529-1534	CARDINAL
bptjm-41	116	1	9	CARDINAL
bptjm-41	116	2	lambert dw	PERSON
bptjm-41	116	3	turner aj	PERSON
bptjm-41	116	4	porter ke	PERSON
bptjm-41	117	1	2	CARDINAL
bptjm-41	117	2	myo	ORG
bptjm-41	119	1	2008;93(5):579-588	CARDINAL
bptjm-41	119	2	10	CARDINAL
bptjm-41	120	1	cavalcante mb	PERSON
bptjm-41	120	2	nunes adc	PERSON
bptjm-41	120	3	dasatinib	PERSON
bptjm-41	122	1	2020;12(3):2711	CARDINAL
bptjm-41	123	1	doi:10.18632/aging.102772 11	ORG
bptjm-41	124	1	zoico e	PERSON
bptjm-41	124	2	darra e	PERSON
bptjm-41	127	1	2021;11(1	CARDINAL
bptjm-41	128	1	doi:10.1038	ORG
bptjm-41	129	1	kurz dj	PERSON
bptjm-41	129	2	decary s	PERSON
bptjm-41	129	3	hong y	GPE
bptjm-41	131	1	2000;113(20):3613-3622	CARDINAL
bptjm-41	132	1	jcs.113.20.3613 13	DATE
bptjm-41	133	1	gautret p	PERSON
bptjm-41	133	2	parola p	ORG
bptjm-41	133	3	hydroxychloroquine	PERSON
bptjm-41	133	4	covid-19	PERSON
bptjm-41	135	1	2020	DATE
bptjm-41	136	1	doi:10.1101/2020.03.16.20037135 14	ORG
bptjm-41	137	1	boulware dr	PERSON
bptjm-41	137	2	pullen mf	PERSON
bptjm-41	137	3	bangdiwala	GPE
bptjm-41	138	1	covid-19	DATE
bptjm-41	138	2	new england journal of medicine	ORG
bptjm-41	139	1	2020;383(6):517	CARDINAL
bptjm-41	140	1	tang w	PERSON
bptjm-41	140	2	han	NORP
bptjm-41	140	3	hydroxychloroquine	PERSON
bptjm-41	140	4	2019	DATE
bptjm-41	143	1	gao y	PERSON
bptjm-41	143	2	zhou j	PERSON
bptjm-41	143	3	shi y, xia	PERSON
bptjm-41	144	1	shen h-m. friend	PERSON
bptjm-41	145	1	covid-19	DATE
bptjm-41	146	1	2022;18(12):4690-4703	DATE
bptjm-41	148	1	berkeley pharma tech journal	ORG
bptjm-41	148	2	7 17	DATE
bptjm-41	149	1	burdusel	GPE
bptjm-41	152	1	2022;14(10):4195	CARDINAL
bptjm-41	153	1	18	CARDINAL
bptjm-41	155	1	sprague	GPE
bptjm-41	157	1	2020;42(3):937-949	CARDINAL
bptjm-41	158	1	020-00173-5 19	CARDINAL
bptjm-41	159	1	eisenberg t	PERSON
bptjm-41	159	2	knauer h	ORG
bptjm-41	161	1	2009;11(11):1305-1314	DATE
bptjm-41	162	1	doi:10.1038	ORG
bptjm-41	162	2	20	CARDINAL
bptjm-41	163	1	eisenberg t	PERSON
bptjm-41	165	1	2016;22(12):1428-1438	CARDINAL
bptjm-41	166	1	doi:10.1038/nm.4222 21	ORG
bptjm-41	169	1	2018;14(8):1435-1455	CARDINAL
bptjm-41	170	1	22	CARDINAL
bptjm-41	171	1	yoshii sr	ORG
bptjm-41	171	2	mizushima n. monitoring	PERSON
bptjm-41	173	1	2017;18(9):1865	CARDINAL
bptjm-41	175	1	brown-borg	PERSON
bptjm-41	175	2	bartke a. gh	PERSON
bptjm-41	177	1	2012;67a(6):652-660	CARDINAL
bptjm-41	177	2	24	CARDINAL
bptjm-41	178	1	junnila rk	PERSON
bptjm-41	178	2	berryman de	PERSON
bptjm-41	178	3	murrey jw	PERSON
bptjm-41	178	4	kopchick jj	PERSON
bptjm-41	179	1	gh	ORG
bptjm-41	181	1	2013;9(6):366-376	CARDINAL
bptjm-41	182	1	doi:10.1038/nrendo.2013.67 25	ORG
bptjm-41	183	1	olivecrona h	ORG
bptjm-41	183	2	humans1	GPE
bptjm-41	184	1	clinical endocrinology &	ORG
bptjm-41	185	1	1999;84(2):553-560	CARDINAL
bptjm-41	186	1	doi:10.1210	ORG
bptjm-41	186	2	jcem.84.2.5466 26	DATE
bptjm-41	187	1	hong s	GPE
bptjm-41	187	2	kim m-m.	PERSON
bptjm-41	189	1	2018;59:138	CARDINAL
bptjm-41	190	1	doi:10.1016	GPE
bptjm-41	190	2	27	CARDINAL
bptjm-41	191	1	hong s	GPE
bptjm-41	191	2	kim m-m.	PERSON
bptjm-41	193	1	2018;59:138	CARDINAL
bptjm-41	194	1	doi:10.1016	GPE
bptjm-41	194	2	28	CARDINAL
bptjm-41	195	1	mehta hh	PERSON
bptjm-41	195	2	kp	ORG
bptjm-41	195	3	hevener al	PERSON
bptjm-41	195	4	lee kw	PERSON
bptjm-41	198	1	5750	CARDINAL
bptjm-41	200	1	solomon vr	PERSON
bptjm-41	200	2	lee h.	PERSON
bptjm-41	201	1	european journal	ORG
bptjm-41	202	1	doi:10.1016	NORP
bptjm-41	202	2	30	CARDINAL
bptjm-41	203	1	qian m	PERSON
bptjm-41	203	2	liu z	PERSON
bptjm-41	203	3	peng l	PERSON
bptjm-41	208	1	31	CARDINAL
bptjm-41	208	2	jamali f. insulin-sparing	PERSON
bptjm-41	209	1	canadian	NORP
bptjm-41	210	1	1999;77(2):118-123	CARDINAL
bptjm-41	211	1	146 32	DATE
bptjm-41	212	1	schneider jg	PERSON
bptjm-41	212	2	finck bn	ORG
bptjm-41	212	3	ren j	PERSON
bptjm-41	214	1	berkeley pharma tech journal	ORG
bptjm-41	214	2	8	CARDINAL
bptjm-41	215	1	2006;4(5):377-389	CARDINAL
bptjm-41	215	2	doi:10.1016	GPE
bptjm-41	215	3	33	CARDINAL
bptjm-41	216	1	feng c	PERSON
bptjm-41	219	1	2010;51(7):1738	CARDINAL
bptjm-41	220	1	34	CARDINAL
bptjm-41	221	1	blasco ma	PERSON
bptjm-41	221	2	kroemer	PERSON
bptjm-41	224	1	2013;153(6):1194-1217	CARDINAL
bptjm-41	225	1	doi:10.1016	GPE
bptjm-41	225	2	35	CARDINAL
bptjm-41	226	1	maes	PERSON
bptjm-41	228	1	2014;26(2):190	CARDINAL
bptjm-41	229	1	doi:10.1016	GPE
bptjm-41	229	2	36	CARDINAL
bptjm-41	230	1	w	GPE
bptjm-41	230	2	wang b	PERSON
bptjm-41	230	3	yang j	PERSON
bptjm-41	233	1	2014;37(9):1505-1509	DATE
bptjm-41	234	1	doi:10.1248	ORG
bptjm-41	235	1	shen h	ORG
bptjm-41	235	2	wu n	PERSON
bptjm-41	235	3	wang y	PERSON
bptjm-41	238	1	2017;46:16-22	DATE
bptjm-41	239	1	doi:10.1016	GPE
bptjm-41	239	2	38	CARDINAL
bptjm-41	240	1	schrezenmeier e	PERSON
bptjm-41	242	1	2020;16(3):155	CARDINAL
bptjm-41	242	2	doi:10.1038	ORG
bptjm-41	242	3	020-0372	CARDINAL
bptjm-41	242	4	39	CARDINAL
bptjm-41	243	1	longo vd	PERSON
bptjm-41	243	2	antebi	GPE
bptjm-41	246	1	2015;14(4):497-510	CARDINAL
bptjm-41	247	1	doi:10.1111	ORG
bptjm-41	247	2	40	CARDINAL
bptjm-41	248	1	wranicz jk	ORG
bptjm-41	251	1	2006;15(8):521-525	CARDINAL
bptjm-41	252	1	doi:10.1191/0961203306lu2345oa berkeley pharma tech journal	ORG
bptjm-41	252	2	9	CARDINAL